How Teachers Can Defeat AI

As someone also in the academic trenches, I appreciated John J. Goyette's op-ed 'How to Stop Students From Cheating With AI' (May 20). My plan for the autumn semester is to offer an old-school approach: Students who take handwritten notes in physical notebooks will be allowed to take exams 'open book.' Hopefully this will disincentivize using computers in the classroom and reinstill in students the value of note-taking. Perhaps this will even lead to the return of some creative doodling.
Prof. Eric Zolov

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

CBS News

24 minutes ago

• CBS News

Lava fountains over 1,000 feet high shoot from Hawaii's Kilauea volcano

Hawaii's Kilauea volcano sent jets of lava shooting over 1,000 feet into the air early Friday morning, marking another explosive episode for the active volcano. The volcanic activity began at 11:30 p.m. local time Thursday, according to the Hawaiian Volcano Observatory, which is operated by the U.S. Geological Survey. At first, the activity was "small, sporadic spattering" and lava outflows, the observatory said. But as time went on, the activity "continued to increase in intensity." By 1:40 a.m. Friday, the lava fountains erupting from the volcano's north vent were reaching heights of over 1,000 feet, the observatory said. That intensity overlapped with an increase in seismic activity, the observatory said. Fifteen minutes later, at 1:55 a.m. local time, the volcano was continuing to emit 800-foot-high fountains of lava. A camera at the volcano continued to livestream images of impressive lava fountains shooting into the air. Lava erupts from Kilauea on June 20, 2025. U.S. Geological Survey The fountains are feeding a lava flow, the observatory said. The lava flow remains contained in the Halema'uma'u caldera, a crater at the top of the volcano, the observatory said. The volcano also released a volcanic cloud about 15,000 feet into the air. The observatory warned that the plume may include hazards, including strands of volcanic glass known as Pele's hair and rock fragments called tephra. These hazards, along with volcanic gas, can have "far-reaching effects downwind," the observatory said. Winds around the volcano are blowing from the north, so these fragments may be distributed south of the caldera, the observatory said. This is the volcano's 26th lava fountaining episode since December 2024. Most episodes have lasted for a day or less, and are separated by pauses of at least several days, the observatory said. Kilauea, located on the Big Island's Hawaii Volcanoes National Park about 200 miles from Honolulu, is one of six active volcanoes in Hawaii. It is also one of the world's most active volcanoes. Its eruptions have become a popular attraction. The USGS also offers multiple YouTube livestreams of the volcanic activity. Hawaii is also home to the largest active volcano in the world, Mauna Loa. The volcano is also located in Hawaii Volcanoes National Park and last erupted in 2022.

Forbes

an hour ago

• Forbes

Trump Seeks Cuts To STEM Education, Emerging Technology Job Training

In its latest move to undercut university funding, the Trump administration is seeking to slash the ... More U.S. National Science Foundation budget in half, with a 75% cut to its STEM education funding. The agency has funded competitively won grants for scientific research and STEM education since 1950. Community college workforce programs will be implicated along the way. Congress is weighing options as it finalizes appropriations packages this summer. Just a few days after delivering his 100-day address at Macomb Community College in Warren, Michigan, President Donald Trump released a budget proposal that would slash funding for the U.S. National Science Foundation (NSF) by more than half. Its STEM education funding would be cut by 75%. For 75 years, the agency has played an indispensable role in funding STEM workforce training at America's community colleges — just like Macomb. Even though President Trump campaigned on supporting Americans economically and says he wants to boost our tech leadership, the administration is proposing to weaken one of the few avenues left to pursue the American dream through jobs of the future. Community colleges provide credentials that Americans can actually afford, often with a high return on investment — including meaningful salary improvements. NSF funding supports job training at community colleges in one of the global economy's key sectors: STEM, specifically the skilled technical workforce, which requires more education than a high school diploma but not necessarily a four-year degree. More than half of America's 37 million STEM workers are skilled technical workers who power our manufacturing, healthcare and aerospace industries and also are a bedrock of America's middle class. These workers earn more than their counterparts in non-STEM fields even when accounting for education levels. In addition, community colleges are poised to lead on one of the pressing technological issues of our time: artificial intelligence. NSF funding has enabled community colleges to create valuable AI education programs. Enrollment in Miami Dade College's AI program, for example, is already booming. Research we have done at New America including interviews with Miami Dade students has shown that these AI offerings are not just valuable to our youth but also to millions of working adults, including those with bachelor's degrees, who come back to community college to gain practical, industry-aligned skills. Under another NSF grant, Miami Dade has teamed with Houston Community College in Texas and the Maricopa Community College District in Arizona to launch a national consortium to scale AI education at community colleges nationwide, working alongside major employers like Microsoft and Google. Why put these essential training opportunities — and the students and employers who depend on them — at risk? Biotechnology is another emerging technology priority for President Trump and Congress that would be kneecapped by the proposed NSF cuts. Just last month, the Congressional National Security Commission on Emerging Biotechnology, chaired by Sen. Todd Young (R-IN), published a landmark report urging that the U.S. take action over the next three years to reaffirm its global leadership, and that we strengthen investments in biotech workforce education for the health of our citizens, our economy, and our military. The NSF has been leading innovation in biotechnology through community colleges for decades. Since its inception in 1992, its Advanced Technological Education program has invested more than $1.5 billion across more than half of the nation's over 1,200 community colleges, supporting training in automotive tech, cybersecurity innovation, textiles innovation, regenerative medicine, semiconductors, and beyond. When I joined Janet Spriggs, president of Forsyth Tech Community College, on Capitol Hill this year to discuss NSF funds for community college pathways to emerging industries, she made it clear that her institution's biotechnology impact would 'not be possible without NSF funding.' There is no substitute for these resources – not from philanthropy, industry or states. In fact, NSF funding is often seen as a seal of approval needed to convince other funders to make an investment. In the past year, the NSF has made pioneering co-investments in STEM workforce education with major companies including Intel, Micron and GlobalFoundries. Last fall, my own organization partnered with the NSF to launch a $3 million program supported by philanthropy to bolster community college training in emerging technologies relating to the NSF's Regional Innovation Engines grants. Authored under the CHIPS and Science Act, NSF Engines are the broadest investment in place-based, tech-driven economic growth since the Morrill Act created land-grant universities at the height of the Civil War. Skeptics may argue that community colleges can seek funding from other federal agencies. But New America tracks and studies many of those potential sources, and their structure, budget, and funding rules do not allow for the same support of cutting-edge technology education at community colleges. After all, the NSF is the agency charged by law with 'advancing all fields of science and engineering,' including undergraduate and graduate education, and it has an unmatched track record in this pursuit. Since Trump took office, Silicon Valley Venture capitalists, leading economists, politicians, tech executives such as Microsoft President Brad Smith, and leaders of local chambers of Commerce have warned that NSF cuts would hurt America's AI leadership, national security, startups, and economic growth. Adding to that list is our skilled technical workforce and the community colleges that prepare them for good jobs of today and tomorrow. Preserving the NSF and its budget should be a no-brainer, nonpartisan priority. The country's future looks bleaker without it.

Yahoo

an hour ago

• Yahoo

Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States

Tandem continues to build its technology ecosystem to expand choice and personalization for people living with diabetes SAN DIEGO, June 20, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott's FreeStyle Libre® 3 Plus continuous glucose monitoring (CGM) sensor. The Company has initiated an early access program in the United States (U.S.), and intends to scale availability in the second half of 2025. "Diabetes management is not one-size-fits-all and it is critical for people living with diabetes to be able to personalize their AID systems to fit their unique healthcare and lifestyle needs," said Dr. Jordan Pinsker, chief medical officer of Tandem Diabetes Care. "The American Diabetes Association recommends AID systems as the preferred insulin delivery method in people with type 1 and other types of insulin-deficient diabetes, and this integration with Abbott's latest generation sensor allows even more CGM users to access the life-changing benefits of our Control-IQ+ technology." The FreeStyle Libre 3 Plus sensor has an extended 15-day wear time, transmitting automatic glucose readings every minute directly to the pump. This data is also available to view on the Tandem t:slim mobile app, providing users with multiple, convenient ways to access their current glucose trend. The t:slim X2 insulin pump is powered by Control-IQ+ technology, the latest generation of Tandem's advanced hybrid closed-loop algorithm, which adjusts insulin every 5 minutes based on predicted glucose values. It's the only system with the unique AutoBolus™ feature that calculates and delivers a correction bolus to help with missed meal boluses.* Control-IQ+ is easy to start, use, and personalize, and this latest integration works with the FreeStyle Libre 3 Plus sensor and extends its benefits to even more people with diabetes. "This is an exciting first step in our strategy to connect Tandem's portfolio of insulin pumps to Abbott's FreeStyle Libre 3 Plus sensors worldwide," said John Sheridan, president and chief executive officer of Tandem Diabetes Care. "We look forward to expanding access to our t:slim X2 users outside of the U.S. beginning later this year." When available, Tandem will email eligible users in the U.S. with more information.† About Tandem Diabetes CareTandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit Follow Tandem Diabetes Care on X @tandemdiabetes; use #tslimX2 #TandemMobi and # Tandem Diabetes Care on Facebook at Tandem Diabetes Care on LinkedIn at Forward Looking StatementsThis press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, our ability to provide the software update for current t:slim X2 pump users and the t:slim X2 pumps pre-loaded with Freestyle Libre 3 Plus sensor integration software. These statements are subject to numerous risks and uncertainties, including our ability to sustain commercial scale manufacturing of the t:slim X2 pumps pre-loaded with Freestyle Libre 3 Plus sensor integration software, our ability to operate and maintain a system to facilitate online training for existing t:slim X2 pump customers upgrading their existing devices, and the risk that we may encounter other challenges that may delay the availability of the software update for current t:slim X2 pump users or the t:slim X2 pumps pre-loaded with Freestyle Libre 3 Plus sensor integration software. These and other risks are identified and described in greater detail under the "Risk Factors" heading of our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other documents filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Actual results could differ materially from those anticipated or projected in the forward-looking statements. Tandem undertakes no obligation to update or review any forward-looking statement in this press release because of new information, future events, or other factors. Important Safety Information – FreeStyle Libre SystemsProduct for prescription only; for Important Safety Information, please visit Important Safety Information – Tandem Diabetes CareRX ONLY. The t:slim X2 pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater. Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of Type 1 diabetes mellitus in persons 2 years of age and greater and of Type 2 diabetes mellitus in persons 18 years of age and greater. WARNING: Control-IQ+ should not be used in anyone under the age of 2 years old with Type 1 diabetes or under the age of 18 years old with Type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely. Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit for additional important safety information. © 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, the Tandem logo, Control-IQ+, t:slim X2, t:slim, and Tandem Mobi are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. All other third-party marks are the property of their respective owners. * If glucose values are predicted to be above 180 mg/dL (or 10.0 mmol/L), Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL (or 6.1 mmol/L) and delivers 60% of that value. † Future updates for all or some Tandem products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion. View source version on Contacts Media Contact: 858-366-6900media@ Investor Contact: 858-366-6900IR@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data